Lb Pharmaceuticals Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Lb Pharmaceuticals Inc's ROA in the second quarter of 2026?
Lb Pharmaceuticals Inc recorded a cumulative net loss of $-61 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -21.6%.

However, within the Healthcare sector 371 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from to 3075.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) III. Quarter
Y / Y Total Assets Change	998.2 %	-	-	-	-
Y / Y Net Income Change	-	-	-76.35 %	-	-
Net Income (TTM) in million	-61	-14	0	44	34
Return On Assets (TTM)	-21.6 %	-7.04 %	-0.03 %	49.89 %	396.5 %
LBRX's Total Ranking	# 3075	#	#	#	#
Total Assets (TTM) in million	372	393	34	321	34
Seq. Total Assets Change	-5.36 %	1060.44 %	-89.43 %	845.93 %	-
Seq. Net Income Change	-	-	-	-	-

LBRX's 5 Years Annual ROA >> Back to LBRX Management Effectiveness >> Compare LBRX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 135
Sector	# 372
Overall	# 3465

Return On Assets Statistics
High	Average	Low
-7.05 %	-14.43 %	-21.81 %
(Mar 31 2026)		(Jun 30 2026)

Financial Statements
Lb Pharmaceuticals Inc's Assets	$ 372 million	LBRX's Balance sheet
Lb Pharmaceuticals Inc's Income	$ -52 million	Quarterly LBRX's Income Statement
LBRX's Income by Division		See LBRX's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2025	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	34	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	0	0	0	0	0
Annual Return On Assets	-0.19 %	-	-	-	-

LBRX's 5 Years Annual ROA >> Back to LBRX Management Effectiveness >> Compare LBRX ROA to its Competitors

More Return On Assets Ratios
LBRX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
LBRX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for LBRX's Competitors
Subscribers only: Roa for Lb Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Assets for LBRX's Customers

You may also want to know
LBRX's Roi	LBRX's Inventory Turnover Ratio	LBRX's Growth Rates	LBRX's Dividend Comparisons
	LBRX's Profitability Ratios	LBRX's Asset Turnover Ratio	LBRX's Dividend Growth
LBRX's Roe	LBRX's Valuation Ratios	LBRX's Financial Strength Ratios	LBRX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:43:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.